Association of HMGA2 Polymorphisms with Glioma Susceptibility in Chinese Children
Autor: | Li Yuan, Pan Wang, Jingying Zhou, Hanqi Dai, Ran Zhang, Xiaokai Huang, Jichen Ruan |
---|---|
Rok vydání: | 2021 |
Předmět: |
0301 basic medicine
medicine.medical_specialty HMGA2 Single-nucleotide polymorphism Gastroenterology susceptibility polymorphism 03 medical and health sciences 0302 clinical medicine Pharmacogenomics and Personalized Medicine Polymorphism (computer science) glioma Internal medicine Glioma Genotype medicine Original Research Pharmacology biology business.industry Odds ratio medicine.disease Confidence interval 030104 developmental biology Increased risk 030220 oncology & carcinogenesis biology.protein Molecular Medicine business |
Zdroj: | Pharmacogenomics and Personalized Medicine |
ISSN: | 1178-7066 |
DOI: | 10.2147/pgpm.s310780 |
Popis: | Jingying Zhou,1 Pan Wang,1 Ran Zhang,2 Xiaokai Huang,1 Hanqi Dai,1 Li Yuan,3 Jichen Ruan1 1Department of Hematology, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, 325027, Zhejiang, People’s Republic of China; 2Sydney School of Public Health, The University of Sydney, Camperdown, Sydney, NSW, 2006, Australia; 3Department of Pathology, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou, 510623, Guangdong, People’s Republic of ChinaCorrespondence: Jichen RuanDepartment of Hematology, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, 109 West Xueyuan Road, Wenzhou, 325027, Zhejiang, People’s Republic of ChinaEmail delcruanjichen@163.comLi YuanDepartment of Pathology, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, 9 Jinsui Road, Guangzhou, 510623, Guangdong, People’s Republic of ChinaEmail lizzyklarck@126.comBackground: Glioma is a malignant central nervous system tumor in children, with poor outcomes and prognosis. HMGA2 is a proto-oncogene with increased expression in various malignancies.Methods: We explored the association of HMGA2 polymorphisms with glioma susceptibility in Chinese children using a case-control study (191 cases, 248 controls). HMGA2 single nucleotide polymorphisms (rs6581658 A>G; rs8756 A>C; rs968697 T>C) were genotyped using PCR-based TaqMan.Results: Increased glioma susceptibility was associated with rs6581658 A>G; AG (adjusted odds ratio (OR) = 1.71, 95% confidence interval (CI) = 1.13– 2.58, P = 0.010) or GG (adjusted OR = 3.12, 95% CI = 1.26– 7.74, P = 0.014) genotype carriers had significantly raised glioma risk compared with AA genotype carriers. The rs6581658 AG/GG (adjusted OR = 1.85, 95% CI = 1.25– 2.73, P = 0.002) and AA/GG (adjusted OR = 2.58, 95% CI = 1.05– 6.33, P = 0.038) genotypes were associated with an increased risk of glioma relative to the AA genotype. Subjects with 2– 3 risk genotypes had a significantly elevated risk (adjusted OR = 1.93, 95% CI = 1.31– 2.84, P = 0.001) relative to those with 0– 1 risk genotype.Conclusion: HMGA2 rs6581658 A>G is associated with glioma susceptibility in Chinese children.Keywords: HMGA2, polymorphism, susceptibility, glioma |
Databáze: | OpenAIRE |
Externí odkaz: |